| Trial ID: | L3235 |
| Source ID: | NCT03962686
|
| Associated Drug: |
Statin Oral Tablet Plus Pcsk9i
|
| Title: |
Molecular Mechanisms and Carotid Atherosclerosis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Atherosclerosis of Artery|Atherosclerotic Plaque
|
| Interventions: |
DRUG: statin Oral Tablet plus PCSK9i
|
| Outcome Measures: |
Primary: methylase status, to evaluate the activity (over vs. hypo activation) of methylase complex in atherosclerotic carotid plaques of normoglycemics vs. DM patients, and of DM patients treated with statin vs. DM patients previous treated by statin plus PCSK9i, 12 months |
|
| Sponsor/Collaborators: |
Sponsor: University of Campania Luigi Vanvitelli
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
76
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2015-01-01
|
| Completion Date: |
2018-01-01
|
| Results First Posted: |
|
| Last Update Posted: |
2022-08-03
|
| Locations: |
Raffaele Marfella, Naples, 80138, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT03962686
|
